http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2013014007-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5355
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0463
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5355
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
filingDate 2012-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c524fc5ee0715def6de134ac4f9d308
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_520f33558afc03a605e7c82123805a40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61b7fd4bbec84335debed33adb09590f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6de2030fd970a6395850c836d380a506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbac162bb593d4df4c38029729b259d1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71a09f7b6ded4abf20af4878000b8829
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea1add34d37a5f60ef98e3fa58d721db
publicationDate 2014-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2013014007-A
titleOfInvention [1,3] OXAZINES.
abstract The present invention relates to compounds of formula (I) which have inhibitory activity of BACE1 and / or BACE2, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active substances. The active compounds of the present invention are useful in the therapeutic and / or prophylactic treatment of, for example, Alzheimer's disease and type 2 diabetes. The invention further provides a derivative thereof radiolabelled.
priorityDate 2011-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID23821
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID29392
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25825
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID288227
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID614333
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID585631
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID56175
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15560522
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421208097
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID23621

Total number of triples: 35.